News/Pharmaceutical Research and Manufacturers of America (PhRMA)

Pharmaceutical Companies Are Using Virtual Assistants for Medical Affairs and Administrative Support in 2026

Virtual Assistant News Desk·

Pharmaceutical companies operate in a world of extraordinary administrative complexity. Drug development, regulatory compliance, commercial operations, and medical affairs each generate their own dense layers of documentation, communication, and coordination requirements. As product portfolios grow and global operations expand, the administrative overhead required to support core scientific and commercial functions has become a material operational cost.

In 2026, pharmaceutical companies of all sizes — from global top-20 pharma to commercial-stage specialty biotech — are deploying virtual assistants to manage the administrative infrastructure that surrounds their highest-value professional functions.

Medical Affairs: The Administrative Burden Behind Scientific Strategy

Medical affairs has evolved significantly over the past decade. What was once a support function for commercial teams is now a strategic pillar responsible for scientific communication, real-world evidence generation, health economics and outcomes research (HEOR), and medical information services. The Pharmaceutical Research and Manufacturers of America (PhRMA) notes that the role of medical science liaisons (MSLs) — the field-facing members of medical affairs teams — has expanded to include complex evidence communication, clinical trial recruitment support, and formulary access discussions.

MSLs are highly trained scientific professionals. Their time is most valuable when spent in one-on-one scientific exchanges with key opinion leaders (KOLs), presenting at medical society congresses, and providing post-marketing evidence to payer medical directors. Yet MSLs consistently report significant time spent on administrative tasks: literature searches, congress logistics, CRM data entry, and meeting preparation.

Virtual assistants handle the administrative work surrounding MSL activity: scheduling medical congress meetings, preparing KOL engagement briefings, maintaining CRM records of scientific exchange documentation, tracking publication and abstract submission deadlines, and coordinating speaker honoraria processing. This support allows MSLs to operate at the top of their training and expertise.

Medical Information Request Management

Pharmaceutical companies are legally and ethically required to respond accurately and promptly to unsolicited medical information requests from healthcare providers and patients. Managing this function involves triaging inbound inquiries, routing them to appropriate medical reviewers, tracking response timelines for compliance purposes, and maintaining documentation logs.

Virtual assistants handle the intake and routing tier of medical information management: logging inbound requests in the medical information database, confirming receipt to the requester, routing to the appropriate therapeutic area reviewer based on defined triage criteria, and tracking response deadlines. The Drug Information Association (DIA) cites studies showing that pharmaceutical companies receive hundreds to thousands of medical information inquiries per year per product — a volume that requires systematic management infrastructure.

By handling intake, routing, and documentation tracking, VAs allow medical information specialists to focus entirely on the scientific review and response drafting rather than administrative case management.

KOL Engagement and Advisory Board Coordination

Key opinion leader engagement is central to medical affairs strategy. Advisory boards, consulting arrangements, and speaker programs require meticulous logistical and documentation support: contract execution, fair market value rate compliance, meeting planning, travel coordination, and disclosure reporting under the Sunshine Act.

Virtual assistants manage advisory board logistics: sending calendar invitations, coordinating travel arrangements in compliance with company policy and anti-kickback guidelines, preparing agenda packets, distributing pre-reading materials, and managing post-meeting documentation including attendance records and consultant payment processing. The administrative complexity of Sunshine Act compliance — ensuring that every transfer of value to a healthcare provider is accurately reported to CMS — requires organized documentation management that VAs can provide systematically.

Commercial and Corporate Administrative Operations

Beyond medical affairs, pharmaceutical companies require broad administrative support across commercial operations, regulatory affairs, legal, finance, and human resources. Executive calendar management, board meeting preparation, vendor contract administration, travel and expense management, and procurement coordination are functions that virtual assistants handle reliably.

For regional or mid-sized pharmaceutical companies that cannot justify full administrative staffing at every site, VAs provide flexible coverage that scales with the company's operational needs. According to the Bureau of Labor Statistics, the average annual cost of an administrative assistant in the pharmaceutical sector exceeds $50,000 in major markets — a cost that VA arrangements can reduce significantly while maintaining output quality.

Pharmaceutical companies building scalable administrative infrastructure across medical affairs and commercial operations can explore VA solutions at Stealth Agents.


Sources

  • Pharmaceutical Research and Manufacturers of America (PhRMA), Medical Affairs Function Report, 2024
  • Drug Information Association (DIA), Medical Information Benchmarking Study, 2024
  • Centers for Medicare and Medicaid Services (CMS), Open Payments / Sunshine Act Data, 2024
  • Bureau of Labor Statistics, Pharmaceutical Sector Administrative Wages, 2024
  • Medical Science Liaison Society, MSL Productivity Survey, 2024